Table 2. Multivariate Cox proportional hazard models for RFS and OS in the FUSCC cohort.
LN, lymph node; LVI, lymphovascular invasion; HR, hormone receptor; TNBC, triple-negative breast cancer.
| Variables | RFS | OS | |||
|---|---|---|---|---|---|
| Hazard ratio (95% CI) | P | Hazard ratio (95% CI) | P | ||
| Tumor size | – | 0.95 (0.75–1.22) | 0.71 | 1.01 (0.74–1.38) | 0.93 |
| Positive LN | – | 1.08 (1.05–1.10) | <0.001 | 1.10 (1.06–1.14) | <0.001 |
| LVI | Negative | Ref | |||
| Positive | 1.91 (1.07–3.42) | 0.03 | 0.88 (0.38–2.04) | 0.77 | |
| Clinical subtype | HR+HER2− | Ref | |||
| HR+HER2+ | 0.77 (0.26–2.24) | 0.63 | 1.36 (0.28–6.57) | 0.70 | |
| HR−HER2+ | 1.90 (0.86–4.22) | 0.11 | 5.21 (1.81–15.05) | 0.002 | |
| TNBC | 1.66 (0.93–2.96) | 0.09 | 2.08 (0.82–5.26) | 0.12 | |
| IITH | Low | Ref | |||
| High | 2.15 (1.22–3.80) | 0.008 | 3.02 (1.24–7.33) | 0.01 | |